Other studies have described that the potentiation of HGF/MET activation by ectopic expression of HGF leads to hepatic, renal, and gut abnormalities [8,9,10,11], whereas MET overexpression confers susceptibility to tumor development [12,13,14]. The gene discussed is HGF; the disease is neoplasm.